{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:10:56Z","timestamp":1792213856656,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bioactive peptides such as anticancer peptides (ACPs) offer a promising therapeutic alternative to small molecules due to their efficiency and selectivity against tumors and minimal toxicity towards healthy human cells. However, their rational discovery requires navigating a vast chemical space using computationally demanding in silico tools. Herein, we present a computational method enabling cost-efficient exploration of large peptide libraries using reinforcement learning and posterior sampling. Practical application of the developed approach results in identification of membranolytic peptides with therapeutic potential. The developed computational method reduces the search space by over 90% compared to exhaustive library screening and enables effective balancing between dataset\u2019s exploration and exploitation. We demonstrate the scalability of this method by screening a focused library of 36 million structurally resolved helical peptides curated from the Protein Data Bank. When screened in in vitro assays, 15 of the top 100 selected candidates exhibit cytotoxic activity against breast cancer cells including drug resistant triple-negative breast cancer, with the three lead compounds further characterizing as non-toxic towards healthy human cells. This study highlights the potential of using deep reinforcement learning to expedite bioactive peptide discovery, offering a promising path for developing new peptide-based cancer therapies.<\/jats:p>","DOI":"10.1038\/s41467-025-66748-y","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:17:24Z","timestamp":1764267444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A scalable reinforcement learning approach for screening large peptide libraries for bioactive peptide discovery"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2562-7155","authenticated-orcid":false,"given":"Mohit","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Massah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan A.","family":"Alford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem","family":"Mslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopeshh","family":"Subbaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-1976","authenticated-orcid":false,"given":"Francesco","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8665-8641","authenticated-orcid":false,"given":"Nada","family":"Lallous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-770X","authenticated-orcid":false,"given":"Evan F.","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-8503","authenticated-orcid":false,"given":"Robert E. W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-1439","authenticated-orcid":false,"given":"Artem","family":"Cherkasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"66748_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"66748_CR2","doi-asserted-by":"publisher","first-page":"D837","DOI":"10.1093\/nar\/gku892","volume":"43","author":"A Tyagi","year":"2015","unstructured":"Tyagi, A. et al. CancerPPD: a database of anticancer peptides and proteins. Nucleic Acids Res. 43, D837\u2013D843 (2015).","journal-title":"Nucleic Acids Res."},{"key":"66748_CR3","doi-asserted-by":"publisher","first-page":"200004","DOI":"10.1098\/rsob.200004","volume":"10","author":"M Xie","year":"2020","unstructured":"Xie, M., Liu, D. & Yang, Y. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol. 10, 200004 (2020).","journal-title":"Open Biol."},{"key":"66748_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/ijo.2020.5099","volume":"57","author":"W Chiangjong","year":"2020","unstructured":"Chiangjong, W., Chutipongtanate, S. & Hongeng, S. Anticancer peptide: physicochemical property, functional aspect and trend in clinical application (Review). Int. J. Oncol. 57, 678\u2013696 (2020).","journal-title":"Int. J. Oncol."},{"key":"66748_CR5","doi-asserted-by":"publisher","first-page":"114996","DOI":"10.1016\/j.biopha.2023.114996","volume":"164","author":"RK Chinnadurai","year":"2023","unstructured":"Chinnadurai, R. K. et al. Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications. Biomed. Pharmacother. 164, 114996 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"66748_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/molecules28031148","volume":"28","author":"G Ghaly","year":"2023","unstructured":"Ghaly, G. et al. Anti-cancer peptides: status and future prospects. Molecules 28, 1148 (2023).","journal-title":"Molecules"},{"key":"66748_CR7","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3390\/pharmaceutics14122686","volume":"14","author":"AK Tripathi","year":"2022","unstructured":"Tripathi, A. K. & Vishwanatha, J. K. Role of anti-cancer peptides as immunomodulatory agents: potential and design strategy. Pharmaceutics 14, 2686 (2022).","journal-title":"Pharmaceutics"},{"key":"66748_CR8","doi-asserted-by":"publisher","first-page":"110194","DOI":"10.1016\/j.cbi.2022.110194","volume":"368","author":"P Norouzi","year":"2022","unstructured":"Norouzi, P., Mirmohammadi, M. & Houshdar Tehrani, M. H. Anticancer peptides mechanisms, simple and complex. Chem. Biol. Interact. 368, 110194 (2022).","journal-title":"Chem. Biol. Interact."},{"key":"66748_CR9","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox, C. et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 52, D1265\u2013D1275 (2024).","journal-title":"Nucleic Acids Res."},{"key":"66748_CR10","unstructured":"Home | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/."},{"key":"66748_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41551-022-00991-2","volume":"7","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences. Nat. Biomed. Eng. 7, 797\u2013810 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"66748_CR12","doi-asserted-by":"publisher","first-page":"114766","DOI":"10.1016\/j.ejmech.2022.114766","volume":"243","author":"NM Tripathi","year":"2022","unstructured":"Tripathi, N. M. & Bandyopadhyay, A. High throughput virtual screening (HTVS) of peptide library: Technological advancement in ligand discovery. Eur. J. Med. Chem. 243, 114766 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"66748_CR13","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1080\/07391102.2023.2226744","volume":"42","author":"SK Patnaik","year":"2024","unstructured":"Patnaik, S. K. et al. Virtual high throughput screening of natural peptides against ErbB1 and ErbB2 to identify potential inhibitors for cancer chemotherapy. J. Biomol. Struct. Dyn. 42, 5551\u20135574 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"66748_CR14","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/ijms25031798","volume":"25","author":"M Vincenzi","year":"2024","unstructured":"Vincenzi, M., Mercurio, F. A. & Leone, M. Virtual screening of peptide libraries: the search for peptide-based therapeutics using computational tools. Int. J. Mol. Sci. 25, 1798 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"66748_CR15","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1093\/bioinformatics\/btx285","volume":"33","author":"AT M\u00fcller","year":"2017","unstructured":"M\u00fcller, A. T., Gabernet, G., Hiss, J. A. & Schneider, G. modlAMP: Python for antimicrobial peptides. Bioinformatics 33, 2753\u20132755 (2017).","journal-title":"Bioinformatics"},{"key":"66748_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41551-021-00689-x","volume":"5","author":"P Das","year":"2021","unstructured":"Das, P. et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat. Biomed. Eng. 5, 613\u2013623 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"66748_CR17","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1021\/acs.jcim.1c00181","volume":"61","author":"J Chen","year":"2021","unstructured":"Chen, J., Cheong, H. H. & Siu, S. W. I. xDeep-AcPEP: deep learning method for anticancer peptide activity prediction based on convolutional neural network and multitask learning. J. Chem. Inf. Model 61, 3789\u20133803 (2021).","journal-title":"J. Chem. Inf. Model"},{"key":"66748_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/91201034","volume":"9","author":"A Cherkasov","year":"2004","unstructured":"Cherkasov, A. & Jankovic, B. Application of \u2018inductive\u2019 QSAR descriptors for quantification of antibacterial activity of cationic polypeptides. Molecules 9, 1034\u20131052 (2004).","journal-title":"Molecules"},{"key":"66748_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbac630","volume":"24","author":"Q Yuan","year":"2023","unstructured":"Yuan, Q., Chen, K., Yu, Y., Le, N. Q. K. & Chua, M. C. H. Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding. Brief Bioinform. 24, 1\u201310 (2023).","journal-title":"Brief Bioinform."},{"key":"66748_CR20","doi-asserted-by":"publisher","first-page":"16820","DOI":"10.1021\/acsomega.4c01374","volume":"9","author":"M Xu","year":"2024","unstructured":"Xu, M., Pang, J., Ye, Y. & Zhang, Z. Integrating traditional machine learning and deep learning for precision screening of anticancer peptides: a novel approach for efficient drug discovery. ACS Omega 9, 16820\u201316831 (2024).","journal-title":"ACS Omega"},{"key":"66748_CR21","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/molecules27051544","volume":"27","author":"M Sun","year":"2022","unstructured":"Sun, M., Yang, S., Hu, X. & Zhou, Y. ACPNet: a deep learning network to identify anticancer peptides by hybrid sequence information. Molecules 27, 1544 (2022).","journal-title":"Molecules"},{"key":"66748_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ymeth.2022.07.017","volume":"207","author":"J Liu","year":"2022","unstructured":"Liu, J., Li, M. & Chen, X. AntiMF: a deep learning framework for predicting anticancer peptides based on multi-view feature extraction. Methods 207, 38\u201343 (2022).","journal-title":"Methods"},{"key":"66748_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02703-3","volume":"11","author":"S Ahmed","year":"2021","unstructured":"Ahmed, S. et al. ACP-MHCNN: an accurate multi-headed deep-convolutional neural network to predict anticancer peptides. Sci. Rep. 11, 23676 (2021).","journal-title":"Sci. Rep."},{"key":"66748_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbab008","volume":"22","author":"Z Lv","year":"2021","unstructured":"Lv, Z., Cui, F., Zou, Q., Zhang, L. & Xu, L. Anticancer peptides prediction with deep representation learning features. Brief. Bioinform. 22, 1\u201314 (2021).","journal-title":"Brief. Bioinform."},{"key":"66748_CR25","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1016\/j.csbj.2022.07.043","volume":"20","author":"L Thi Phan","year":"2022","unstructured":"Thi Phan, L. et al. MLACP 2.0: An updated machine learning tool for anticancer peptide prediction. Comput Struct. Biotechnol. J. 20, 4473\u20134480 (2022).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"66748_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbaa153","volume":"22","author":"P Agrawal","year":"2021","unstructured":"Agrawal, P., Bhagat, D., Mahalwal, M., Sharma, N. & Raghava, G. P. S. AntiCP 2.0: an updated model for predicting anticancer peptides. Brief. Bioinform. 22, 1\u201312 (2021).","journal-title":"Brief. Bioinform."},{"key":"66748_CR27","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bib\/bbz088","volume":"21","author":"B Rao","year":"2020","unstructured":"Rao, B., Zhou, C., Zhang, G., Su, R. & Wei, L. ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides. Brief. Bioinform. 21, 1846\u20131855 (2020).","journal-title":"Brief. Bioinform."},{"key":"66748_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.04.025","volume":"17","author":"HC Yi","year":"2019","unstructured":"Yi, H. C. et al. ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation. Mol. Ther. Nucleic Acids 17, 1\u20139 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"66748_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.omtn.2020.10.005","volume":"22","author":"L Yu","year":"2020","unstructured":"Yu, L., Jing, R., Liu, F., Luo, J. & Li, Y. DeepACP: a novel computational approach for accurate identification of anticancer peptides by Deep Learning Algorithm. Mol. Ther. Nucleic Acids 22, 862\u2013870 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"66748_CR30","doi-asserted-by":"publisher","first-page":"105868","DOI":"10.1016\/j.compbiomed.2022.105868","volume":"148","author":"L Zhu","year":"2022","unstructured":"Zhu, L., Ye, C., Hu, X., Yang, S. & Zhu, C. ACP-check: an anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy. Comput Biol. Med 148, 105868 (2022).","journal-title":"Comput Biol. Med"},{"key":"66748_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016239118","volume":"118","author":"A Rives","year":"2021","unstructured":"Rives, A. et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proc. Natl. Acad. Sci. USA 118, e2016239118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66748_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/pharmaceutics14050997","volume":"14","author":"JS Hwang","year":"2022","unstructured":"Hwang, J. S. et al. Development of anticancer peptides using artificial intelligence and combinational therapy for cancer therapeutics. Pharmaceutics 14, 997 (2022).","journal-title":"Pharmaceutics"},{"key":"66748_CR33","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1021\/acs.jcim.4c00295","volume":"64","author":"S Bhattarai","year":"2024","unstructured":"Bhattarai, S., Tayara, H. & Chong, K. T. Advancing peptide-based cancer therapy with AI: in-depth analysis of state-of-the-art AI models. J. Chem. Inf. Model 64, 4941\u20134957 (2024).","journal-title":"J. Chem. Inf. Model"},{"key":"66748_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae275","volume":"25","author":"M Goles","year":"2024","unstructured":"Goles, M. et al. Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides. Brief. Bioinform 25, bbae275 (2024).","journal-title":"Brief. Bioinform"},{"key":"66748_CR35","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.2174\/1389203721666200117171403","volume":"21","author":"S Basith","year":"2020","unstructured":"Basith, S., Manavalan, B., Shin, T. H., Lee, D. Y. & Lee, G. Evolution of machine learning algorithms in the prediction and design of anticancer peptides. Curr. Protein Pept. Sci. 21, 1242\u20131250 (2020).","journal-title":"Curr. Protein Pept. Sci."},{"key":"66748_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138880","volume":"290","author":"J Yue","year":"2025","unstructured":"Yue, J. et al. Discovery of anticancer peptides from natural and generated sequences using deep learning. Int. J. Biol. Macromol. 290, 138880 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"66748_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1021\/acsmedchemlett.1c00556","volume":"13","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Large-scale screening of antifungal peptides based on quantitative structure\u2013activity Relationship. ACS Med. Chem. Lett. 13, 99\u2013104 (2021).","journal-title":"ACS Med. Chem. Lett."},{"key":"66748_CR38","doi-asserted-by":"publisher","unstructured":"Ko\u017ami\u0144ski, W. Sparse sampling in NMR. Encyclopedia of Biophysics 2418\u20132419. https:\/\/doi.org\/10.1007\/978-3-642-16712-6_348 (2013).","DOI":"10.1007\/978-3-642-16712-6_348"},{"key":"66748_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jmr.2008.05.011","volume":"193","author":"JC Hoch","year":"2008","unstructured":"Hoch, J. C., Maciejewski, M. W. & Filipovic, B. Randomization improves sparse sampling in multidimensional NMR. J. Magn. Reson. 193, 317\u2013320 (2008).","journal-title":"J. Magn. Reson."},{"key":"66748_CR40","doi-asserted-by":"publisher","first-page":"10835","DOI":"10.1039\/C2CP40174F","volume":"14","author":"M Mobli","year":"2012","unstructured":"Mobli, M., MacIejewski, M. W., Schuyler, A. D., Stern, A. S. & Hoch, J. C. Sparse sampling methods in multidimensional NMR. Phys. Chem. Chem. Phys. 14, 10835\u201310843 (2012).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"66748_CR41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cbic.201402581","volume":"16","author":"LE Uggerh\u00f8j","year":"2015","unstructured":"Uggerh\u00f8j, L. E. et al. Rational design of alpha-helical antimicrobial peptides: do\u2019s and don\u2019ts. ChemBioChem 16, 242\u2013253 (2015).","journal-title":"ChemBioChem"},{"key":"66748_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s13238-014-0061-0","volume":"5","author":"Y Huang","year":"2014","unstructured":"Huang, Y. et al. Role of helicity of \u03b1-helical antimicrobial peptides to improve specificity. Protein Cell 5, 631\u2013642 (2014).","journal-title":"Protein Cell"},{"key":"66748_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112841","volume":"220","author":"F Pan","year":"2022","unstructured":"Pan, F. et al. Anticancer effect of rationally designed \u03b1-helical amphiphilic peptides. Colloids Surf. B Biointerfaces 220, 112841 (2022).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"66748_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1389557514666141107120954","volume":"15","author":"Y Huang","year":"2015","unstructured":"Huang, Y., Feng, Q., Yan, Q., Hao, X. & Chen, Y. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs. Mini-Rev. Med. Chem. 15, 73\u201381 (2015).","journal-title":"Mini-Rev. Med. Chem."},{"key":"66748_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcis.2021.08.200","volume":"607","author":"R Hadianamrei","year":"2022","unstructured":"Hadianamrei, R., Tomeh, M. A., Brown, S., Wang, J. & Zhao, X. Rationally designed short cationic \u03b1-helical peptides with selective anticancer activity. J. Colloid Interface Sci. 607, 488\u2013501 (2022).","journal-title":"J. Colloid Interface Sci."},{"key":"66748_CR46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1504\/IJBRA.2024.142546","volume":"20","author":"MA Sofi","year":"2024","unstructured":"Sofi, M. A. & Wani, M. A. IRNN-SS. Int. J. Bioinform. Res. Appl. 20, 608\u2013626 (2024).","journal-title":"Int. J. Bioinform. Res. Appl."},{"key":"66748_CR47","first-page":"3094","volume":"3","author":"T Yang","year":"2020","unstructured":"Yang, T. et al. Efficient deep reinforcement learning via adaptive policy transfer. Int. Jt. Conf. Artif. Intell. 3, 3094\u20133100 (2020).","journal-title":"Int. Jt. Conf. Artif. Intell."},{"key":"66748_CR48","first-page":"143","volume":"12","author":"A Lazaric","year":"2012","unstructured":"Lazaric, A. Transfer in reinforcement learning: a framework and a survey. Adapt. Learn. Optim. 12, 143\u2013173 (2012).","journal-title":"Adapt. Learn. Optim."},{"key":"66748_CR49","doi-asserted-by":"crossref","unstructured":"Du. B. et al. Safe adaptive policy transfer reinforcement learning for distributed multiagent control. In IEEE Transactions on Neural Networks and Learning Systems, vol. 36, 1939\u20131946 (2025).","DOI":"10.1109\/TNNLS.2023.3326867"},{"key":"66748_CR50","doi-asserted-by":"crossref","unstructured":"Geylan, G. et al. PepINVENT: Generative peptide design beyond the natural amino acids. Chem. Sci. 16, 8682\u20138696 (2024).","DOI":"10.1039\/D4SC07642G"},{"key":"66748_CR51","first-page":"9786","volume":"162","author":"M Jain","year":"2022","unstructured":"Jain, M. et al. Biological sequence design with GFlowNets. Proc. Mach. Learn Res. 162, 9786\u20139801 (2022).","journal-title":"Proc. Mach. Learn Res."},{"key":"66748_CR52","unstructured":"Pandey, M., Subbaraj, G., Cherkasov, A., Ester, M. & Bengio, E. Pretraining generative flow networks with inexpensive rewards for molecular graph generation. In Proceedings of the 42nd International Conference on Machine Learning. (eds. Singh, A. et al.) vol. 267. 47781\u201347819 (PMLR, 2025)."},{"key":"66748_CR53","doi-asserted-by":"publisher","unstructured":"Schulman, J., Wolski, F., Dhariwal, P., Radford, A. & Klimov, O. Proximal policy optimization algorithms. https:\/\/doi.org\/10.48550\/arXiv.1707.06347 (2017).","DOI":"10.48550\/arXiv.1707.06347"},{"key":"66748_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1561\/2200000068","volume":"12","author":"A Slivkins","year":"2019","unstructured":"Slivkins, A. Introduction to multi-armed bandits. Found. Trends Mach. Learn. 12, 1\u2013286 (2019).","journal-title":"Found. Trends Mach. Learn."},{"key":"66748_CR55","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nprot.2007.160","volume":"2","author":"K Hilpert","year":"2007","unstructured":"Hilpert, K., Winkler, D. F. H. & Hancock, R. E. W. Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat. Protoc. 2, 1333\u20131349 (2007).","journal-title":"Nat. Protoc."},{"key":"66748_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/i6010063","volume":"6","author":"A Cherkasov","year":"2005","unstructured":"Cherkasov, A. Inductive QSAR descriptors. Distinguishing compounds with antibacterial activity by artificial neural networks. Int. J. Mol. Sci. 6, 63\u201386 (2005).","journal-title":"Int. J. Mol. Sci."},{"key":"66748_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-59745-419-3_8","volume":"494","author":"K Hilpert","year":"2008","unstructured":"Hilpert, K., Fjell, C. D. & Cherkasov, A. Peptide-based drug design. Methods Mol. Biol. 494, 127\u2013159 (2008).","journal-title":"Methods Mol. Biol."},{"key":"66748_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn 45, 5\u201332 (2001).","journal-title":"Mach. Learn"},{"key":"66748_CR59","first-page":"785","volume":"13-17-August-20","author":"T Chen","year":"2016","unstructured":"Chen, T. & Guestrin, C. XGBoost: a scalable tree boosting system. Proc. ACM SIGKDD Int. Conf. Knowl. Discov. Data Min. 13-17-August-2016, 785\u2013794 (2016).","journal-title":"Proc. ACM SIGKDD Int. Conf. Knowl. Discov. Data Min."},{"key":"66748_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0925-2312(91)90023-5","volume":"2","author":"F Murtagh","year":"1991","unstructured":"Murtagh, F. Multilayer perceptrons for classification and regression. Neurocomputing 2, 183\u2013197 (1991).","journal-title":"Neurocomputing"},{"key":"66748_CR61","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fmicb.2013.00294","volume":"4","author":"D Gaspar","year":"2013","unstructured":"Gaspar, D., Veiga, A. S. & Castanho, M. A. R. B. From antimicrobial to anticancer peptides. A review. Front. Microbiol. 4, 294 (2013).","journal-title":"Front. Microbiol."},{"key":"66748_CR62","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1158\/1535-7163.MCT-10-0811","volume":"10","author":"Y Huang","year":"2011","unstructured":"Huang, Y., Wang, X., Wang, H., Liu, Y. & Chen, Y. Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural frameworkhydrophobicity and mechanism of action of anticancer peptide. Mol. Cancer Ther. 10, 416\u2013426 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"66748_CR63","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1039\/C6MD00376A","volume":"7","author":"G Gabernet","year":"2016","unstructured":"Gabernet, G., M\u00fcller, A. T., Hiss, J. A. & Schneider, G. Membranolytic anticancer peptides. Medchemcomm 7, 2232\u20132245 (2016).","journal-title":"Medchemcomm"},{"key":"66748_CR64","first-page":"734","volume":"17","author":"W Shoombuatong","year":"2018","unstructured":"Shoombuatong, W., Schaduangrat, N. & Nantasenamat, C. Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI J. 17, 734\u2013752 (2018).","journal-title":"EXCLI J."},{"key":"66748_CR65","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.peptides.2009.02.004","volume":"30","author":"J-M Wu","year":"2009","unstructured":"Wu, J.-M. et al. Structure and function of a custom anticancer peptide, CB1a. Peptides 30, 839\u2013848 (2009).","journal-title":"Peptides"},{"key":"66748_CR66","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1007\/s00018-005-5373-z","volume":"62","author":"JL Gifford","year":"2005","unstructured":"Gifford, J. L., Hunter, H. N. & Vogel, H. J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 62, 2588\u20132598 (2005).","journal-title":"Cell. Mol. Life Sci."},{"key":"66748_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Structure of PDE3A\u2013SLFN12 complex and structure-based design for a potent apoptosis inducer of tumor cells. Nat. Commun. 12, 1\u201311 (2021).","journal-title":"Nat. Commun."},{"key":"66748_CR68","doi-asserted-by":"publisher","first-page":"23812","DOI":"10.18632\/oncotarget.8068","volume":"7","author":"K Han","year":"2016","unstructured":"Han, K. et al. The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia. Oncotarget 7, 23812\u201323824 (2016).","journal-title":"Oncotarget"},{"key":"66748_CR69","first-page":"5","volume":"5","author":"MR Fel\\\u2019\\icio","year":"2017","unstructured":"Fel\\\u2019\\icio, M. R., Silva, O. N., Gon\u00e7alves, S., Santos, N. C. & Franco, O. L. Peptides with dual antimicrobial and anticancer activities. Front. Chem. 5, 5 (2017).","journal-title":"Front. Chem."},{"key":"66748_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10989-014-9435-7","volume":"21","author":"V Saravanan","year":"2015","unstructured":"Saravanan, V. & Lakshmi, P. T. V. ACPP: a web server for prediction and design of anti-cancer peptides. Int. J. Pept. Res. Ther. 21, 99\u2013106 (2015).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"66748_CR71","doi-asserted-by":"crossref","unstructured":"Lath, A., Santal, A. R., Kaur, N., Kumari, P. & Singh, N. P. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnol. Genet. Eng. Rev. 1\u201340 (2022).","DOI":"10.1080\/02648725.2022.2082157"},{"key":"66748_CR72","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.18632\/oncotarget.23179","volume":"9","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Identification and characterization of novel enhanced cell penetrating peptides for anti-cancer cargo delivery. Oncotarget 9, 5944\u20135957 (2017).","journal-title":"Oncotarget"},{"key":"66748_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183228","volume":"1862","author":"M Arias","year":"2020","unstructured":"Arias, M. et al. Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin. Biochim. Biophys. Acta (BBA) - Biomembr. 1862, 183228 (2020).","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"66748_CR74","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1016\/j.bbamem.2016.09.021","volume":"1858","author":"AL Hilchie","year":"2016","unstructured":"Hilchie, A. L. et al. Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma. Biochim. Et. Biophys. Acta (BBA)-Biomembr. 1858, 3195\u20133204 (2016).","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Biomembr."},{"key":"66748_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbac320","volume":"23","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Accelerating the discovery of anticancer peptides targeting lung and breast cancers with the Wasserstein autoencoder model and PSO algorithm. Brief. Bioinform. 23, 1\u201311 (2022).","journal-title":"Brief. Bioinform."},{"key":"66748_CR76","first-page":"3","volume":"38","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Liu, X., Huang, F., Xiong, Z. & Zhang, W. A multi-modal contrastive diffusion model for therapeutic peptide generation. Proc. AAAI Conf. Artif. Intell. 38, 3\u201311 (2024).","journal-title":"Proc. AAAI Conf. Artif. Intell."},{"key":"66748_CR77","first-page":"11265","volume":"2019-June","author":"R Webster","year":"2019","unstructured":"Webster, R., Rabin, J., Simon, L. & Jurie, F. Detecting overfitting of deep generative networks via latent recovery. Proc. IEEE Comput. Soc. Conf. Comput. Vis. Pattern Recognit. 2019-June, 11265\u201311274 (2019).","journal-title":"Proc. IEEE Comput. Soc. Conf. Comput. Vis. Pattern Recognit."},{"key":"66748_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10989-020-10063-1","volume":"27","author":"P Sharma","year":"2021","unstructured":"Sharma, P. et al. Food-derived anticancer peptides: a review. Int. J. Pept. Res Ther. 27, 55\u201370 (2021).","journal-title":"Int. J. Pept. Res Ther."},{"key":"66748_CR79","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/biom10030456","volume":"10","author":"A Cutone","year":"2020","unstructured":"Cutone, A. et al. Lactoferrin\u2019s anti-cancer properties: safety, selectivity, and wide range of action. Biomolecules 10, 456 (2020).","journal-title":"Biomolecules"},{"key":"66748_CR80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-62703-673-3_11","volume":"1088","author":"S Douglas","year":"2014","unstructured":"Douglas, S., Hoskin, D. W. & Hilchie, A. L. Assessment of antimicrobial (host defense) peptides as anti-cancer agents. Methods Mol. Biol. 1088, 159\u2013170 (2014).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66748-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66748-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66748-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:52:58Z","timestamp":1767073978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66748-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66748"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66748-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11685"}}